Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilon Health (AGL) Other Operating Expenses (2020 - 2025)

Agilon Health (AGL) has disclosed Other Operating Expenses for 6 consecutive years, with $1.8 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Operating Expenses rose 8.28% year-over-year to $1.8 billion, compared with a TTM value of $6.2 billion through Dec 2025, up 32.58%, and an annual FY2025 reading of $6.4 billion, changed N/A over the prior year.
  • Other Operating Expenses was $1.8 billion for Q4 2025 at Agilon Health, up from $1.5 billion in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $1.8 billion in Q4 2025 and bottomed at $151.0 million in Q4 2021.
  • Average Other Operating Expenses over 5 years is $1.0 billion, with a median of $1.0 billion recorded in 2023.
  • Peak annual rise in Other Operating Expenses hit 84.22% in 2021, while the deepest fall reached 51.93% in 2021.
  • Year by year, Other Operating Expenses stood at $151.0 million in 2021, then soared by 323.06% to $638.7 million in 2022, then surged by 59.24% to $1.0 billion in 2023, then skyrocketed by 61.04% to $1.6 billion in 2024, then grew by 8.28% to $1.8 billion in 2025.
  • Business Quant data shows Other Operating Expenses for AGL at $1.8 billion in Q4 2025, $1.5 billion in Q3 2025, and $1.5 billion in Q2 2025.